Employment & Labor Alert — Oklahoma Amends Workplace Drug Testing Law: Key Changes and Next Steps
Oklahoma has passed HB 3127, updating its Medical Marijuana and Patient Protection Act (Okla. Stat. Tit. 63, § 427.8) effective November 1, 2026.
Oklahoma has passed HB 3127, updating its Medical Marijuana and Patient Protection Act (Okla. Stat. Tit. 63, § 427.8) effective November 1, 2026.
On April 20, 2026, President Trump issued a Presidential Determination under the Defense Production Act (“DPA”) to increase domestic energy production in an effort to address shortages related to the ongoing conflict in the Middle East.
Oklahoma legislators are considering SB 277, a proposal that would create a state-run paid family and medical leave insurance program known as the Oklahoma State Paid Family and Medical Leave Insurance Act.
Effective governance depends on informed and engaged board members who understand both their fiduciary responsibilities and the broader organizational ecosystem in which they operate.
The Trump administration’s recent use of the Defense Production Act (“DPA”) to open a segment of a pipeline off the coast of Santa Barbara signals to our energy clients that the exigencies of the ongoing dispute in the Middle East may affect ongoing operations.
The recent Griffin/Stryker litigation shows that for multi state employers, outcomes may turn not only on what a restrictive covenant says, but also on forum selection, governing law, and the employer’s ability to prove protectable interests and irreparable harm early.
A recent decision from the U.S. District Court for the Southern District of New York confirms that when clients independently communicate with a public AI platform, those exchanges are not protected by attorney-client privilege or the work product doctrine.
Hiring decisions carry significant risks. A poor fit can lead to lost time, increased costs, and disruption to culture and operations.